Locations:
Search IconSearch
October 29, 2018/Cancer/News & Insight

Vulnerability and Joy: Two Essentials for Cancer Center Leaders

Why they’re important but so difficult

vulnerability_650x450

Vulnerability and joy are two essentials for leaders of cancer centers, says Brian Bolwell, MD, Chair of Physician Leadership and Development and former Chair of Taussig Cancer Institute. That was his takeaway from the book Daring Greatly by research professor and renowned speaker Brené Brown.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Some of the best talks I have ever heard by leaders occur when they are open about their mistakes, when they admit that they do not have all the answers — when they are vulnerable,” says Dr. Bolwell. “Being vulnerable as a leader can stimulate engagement and connection.”

One part of being vulnerable — particularly in a cancer center environment, he notes — is permitting yourself to experience joy.

“We see tragedy all the time. People in our field are taught to temper joy, to remain even keeled,” he says. “…While what we do is really difficult, it should not be an excuse to disregard the good things in life.”

Read more of Dr. Bolwell’s editorial on vulnerability, joy and Daring Greatly in his October column of Oncology Times.

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad